-+ 0.00%
-+ 0.00%
-+ 0.00%

Pliant Therapeutics Presents Data From Phase 1 Trial Of PLN-101095 At AACR Annual Meeting 2026

Benzinga·03/18/2026 13:03:27
Listen to the news

Pliant Therapeutics, Inc. (NASDAQ:PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced the presentation of data from the Phase 1 trial of PLN-101095 at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California from April 17-22, 2026.

The abstract was selected for oral presentation as part of the Clinical Trials Mini Symposium.